Per Eystein Lønning
Department of Oncology
Haukeland University Hospital
Bergen
Norway
Name/email consistency: high
- Aromatase inhibitors and inactivators for breast cancer therapy. Lønning, P.E. Drugs. Aging (2002)
- The role of aromatase inactivators in the treatment of breast cancer. Lønning, P.E. Int. J. Clin. Oncol. (2002)
- Aromatase inhibitors and inactivators for breast cancer treatment. Lonning, P.E. Eur. J. Cancer (2002)
- Microarrays in primary breast cancer--lessons from chemotherapy studies. Lønning, P.E., Sørlie, T., Perou, C.M., Brown, P.O., Botstein, D., Børresen-Dale, A.L. Endocr. Relat. Cancer (2001)
- Stepwise estrogen suppression manipulating the estrostat. Lønning, P.E. J. Steroid Biochem. Mol. Biol. (2001)
- The potential for aromatase inhibition in breast cancer prevention. Lønning, P.E., Kragh, L.E., Erikstein, B., Hagen, A., Risberg, T., Schlichting, E., Geisler, J. Clin. Cancer Res. (2001)
- Exemestane: a review of its clinical efficacy and safety. Lønning, P.E. Breast (2001)
- Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial. Lønning, P.E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P.D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N.K., Fowst, C., Arkhipov, A., di Salle, E., Polli, A., Massimini, G. J. Clin. Oncol. (2000)
- Is there a growing role for endocrine therapy in the treatment of breast cancer?. Lønning, P.E. Drugs (2000)
- Clinico-pharmacological aspects of different hormone treatments. Lønning, P.E. Eur. J. Cancer (2000)
- Pharmacology and clinical experience with exemestane. Lønning, P.E. Expert. Opin. Investig. Drugs (2000)
- Exemestane in breast cancer: current status and future directions. Lønning, P.E. Clin. Breast Cancer (2000)
